First Trimester Screening Program 2.8

The First Trimester Screening Program by The Fetal Medicine Foundation is a clinical decision-support tool designed to standardize and streamline first-trimester risk assessment. Built on the Foundation’s validated algorithms, it helps healthcare professionals deliver consistent, evidence-based screening during 11 weeks to 13 weeks and 6 days of gestation.

Key features:

• Calculates patient-specific risks for trisomy 21, trisomy 18, and trisomy 13 using maternal age, ultrasound measurements (including crown–rump length and nuchal translucency), and maternal serum biochemistry where available.
• Supports integration of additional ultrasound markers (such as nasal bone, ductus venosus flow, and tricuspid valve assessment) when clinically indicated.
• Incorporates maternal factors to adjust measurements and risks according to established FMF methodology.
• Accommodates singleton and multiple pregnancies with appropriate risk modeling.
• Guides users through structured data entry and produces clear, printable reports to support counseling and documentation.
• Provides tools that support quality assurance and adherence to FMF standards and training.

Intended use:

• For qualified healthcare professionals involved in prenatal care, including FMF-certified practitioners.
• Designed to aid, not replace, clinical judgment. Results depend on the quality of input data and should be interpreted in the context of each patient’s clinical picture and local guidelines.

Note: This software is not a diagnostic device and is not intended for direct use by patients. Always follow your institution’s protocols and regulatory requirements.

First Trimester Screening Program is developed by The Fetal Medicine Foundation and is used by 2 users of Software Informer. The most popular versions of this product among our users are: 2.3, 2.5 and 2.8. The name of the program executable file is FMF.exe.